| For: | Mao EW, Cheng XB, Li WC, Kan CX, Huang N, Wang HS, Hou NN, Sun XD. Association between serum Sestrin2 level and diabetic peripheral neuropathy in type 2 diabetic patients. World J Clin Cases 2021; 9(36): 11156-11164 [PMID: 35071546 DOI: 10.12998/wjcc.v9.i36.11156] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i36/11156.htm |
| Number | Citing Articles |
| 1 |
Hatice Uygun, Zeynep Nur Çiçek, Kenan Ercan, Seyithan Taysi. A Novel Therapeutic Target for Pediatric Pneumonia: Sestrin2. Medicina 2025; 61(11) doi: 10.3390/medicina61111904
|
| 2 |
Shashank M. Patil, Jayanthi M.K., Ramith Ramu. Sestrin 2 as a New Biomarker in Obesity and Diabetes Mellitus: A New Key Player in the Metabolic Regulation. International Journal of Health & Allied Sciences 2024; 13(1) doi: 10.55691/2278-344X.1090
|
| 3 |
Alexander Haidurov, Andrei Budanov. Sestrins as Biomarkers of Cellular Stress and Human Disease. Cells 2026; 15(7) doi: 10.3390/cells15070651
|
| 4 |
Yasameen Nasih Tawfeeq, Riyam Ali Hussin Al-Barwani, Entedhar Rifaat Sarhat, Elham Majeed Mahmood, Zaid Mohammed Mohsin Alshebly. Sestrin-2, and Fructosamine in Serum and Saliva of Patients with Diabetes Mellitus type 2. Journal of Biochemical Technology 2026; 17(1) doi: 10.51847/ED36P69Gz1
|
| 5 |
S. Rooban, K.A. Arul Senghor, V.M. Vinodhini, J.S. Kumar. Sestrin2 at the crossroads of cardiovascular disease and diabetes: A comprehensive review. Obesity Medicine 2024; 51 doi: 10.1016/j.obmed.2024.100558
|
| 6 |
Surbhi Tyagi, Suryakant Nagtilak, Pawan Parashar. Sestrin-2: a new biomarker for type 2 Diabetes Mellitus and Insulin resistance. Journal of Diabetes & Metabolic Disorders 2026; 25(2) doi: 10.1007/s40200-026-02008-0
|
| 7 |
Chunfeng Lu, Yiming Jiang, Wenxuan Xu, Xiaofeng Bao. Sestrin2: multifaceted functions, molecular basis, and its implications in liver diseases. Cell Death & Disease 2023; 14(2) doi: 10.1038/s41419-023-05669-4
|
| 8 |
Shahenda Salah Abdelsalam, Muhammad Ammar Zahid, Sarah Khalaf Ghanem, Abbas Khan, Aijaz Parray, Abdelali Agouni. Sestrin2 Suppression Promotes Endothelial–Mesenchymal Transition and Exacerbates Methylglyoxal-Induced Endothelial Dysfunction. International Journal of Molecular Sciences 2024; 25(24) doi: 10.3390/ijms252413463
|
| 9 |
Xiaodan Zhang, Zirui Luo, Jiahong Li, Yaxuan Lin, Yu Li, Wangen Li. Sestrin2 in diabetes and diabetic complications. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1274686
|